HomeINMB • NASDAQ
add
INmune Bio Inc
Previous close
$1.97
Day range
$1.93 - $2.06
Year range
$1.71 - $11.64
Market cap
53.44M USD
Avg Volume
1.61M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 8.06M | -18.33% |
Net income | -24.46M | -150.95% |
Net profit margin | — | — |
Earnings per share | -0.34 | 31.81% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 33.37M | 7.42% |
Total assets | 37.68M | -28.16% |
Total liabilities | 8.82M | -42.65% |
Total equity | 28.87M | — |
Shares outstanding | 26.59M | — |
Price to book | 1.81 | — |
Return on assets | -53.37% | — |
Return on capital | -67.89% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -24.46M | -150.95% |
Cash from operations | -7.38M | 6.48% |
Cash from investing | -706.00K | — |
Cash from financing | 22.27M | 71.35% |
Net change in cash | 14.04M | 177.03% |
Free cash flow | -4.66M | -4.01% |
About
Founded
2015
Headquarters
Website
Employees
18
